Feedback / Questions
LTI-03 - Rein Therapeutics
https://www.globenewswire.com/news-release/2025/10/09/3164036/28652/en/Rein-Therapeutics-Receives-European-Regulatory-Approval-to-Initiate-Phase-2-Trial-of-LTI-03-in-Idiopathic-Pulmonary-Fibrosis.html
Oct 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next